Fortress Biotech, Inc. Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue -1.05M-1.53M-0.07M-0.67M-1.92M-1.34M0.86M16.48M17.25M26.88M36.63M45.60M68.79M75.74M84.51M57.67M
Cost of Revenue 0.79M3.66M6.12M17.12M14.59M32.08M30.77M22.89M20.88M
Gross Profit -1.05M-1.53M-0.07M-0.67M-1.92M-1.34M0.86M15.69M13.59M20.76M19.51M31.00M36.71M44.97M61.62M36.80M
Operating items
Amortization - Intangibles 3.80M3.42M
Depreciation & Amortization - Total 0.02M0.03M0.40M0.70M
Research & Development 2.27M8.34M8.58M17.47M25.68M10.24M29.81M35.13M48.32M87.38M81.33M64.11M128.87M134.88M101.75M56.63M
Selling, General & Administrative 0.34M0.90M5.75M8.66M10.10M10.41M18.73M28.23M50.90M53.37M55.59M61.17M86.84M113.66M90.98M87.73M
Restructuring Costs 0.32M8.81M
Other Operating Expenses -0.02M2.82M18.11M-1.69M6.12M18.48M14.59M41.62M30.77M34.13M23.69M
Operating Expenses 2.61M9.24M14.34M26.13M35.78M20.65M51.39M82.19M107.04M146.88M147.45M139.87M257.33M279.31M226.85M168.05M
Operating Income -2.61M-9.24M-35.04M-27.18M-35.78M-20.65M-50.53M-65.71M-89.80M-120.00M-110.82M-94.27M-188.54M-203.56M-142.34M-110.38M
EBIT -2.61M-9.24M-35.04M-27.18M-35.78M-20.65M-50.53M-65.71M-89.80M-120.00M-110.82M-94.27M-188.54M-203.56M-142.34M-110.38M
Non-operating items
Non Operating Investment Income 2.33M
Interest & Investment Income 0.06M0.17M0.24M0.55M0.66M0.24M0.30M0.82M1.10M2.56M1.52M0.65M1.40M3.00M2.68M
Other Non Operating Income 0.73M-0.25M0.07M1.22M-3.40M1.32M
Non Operating Income -1.38M0.27M-3.35M-5.58M-7.72M-10.80M9.16M-8.58M24.19M-9.90M-11.29M-10.16M
Net income details
EBT -3.67M-10.71M-34.95M-27.61M-37.16M-21.33M-53.88M-71.29M-97.51M-130.80M-101.66M-102.85M-164.35M-213.46M-153.63M-120.54M
Tax Provisions 1.51M0.14M0.50M0.45M0.52M0.31M
Profit After Tax -3.67M-9.98M-36.36M-27.61M-37.16M-20.39M-53.88M-71.29M-99.84M-141.94M-101.66M-102.98M-164.83M-213.91M-154.15M-120.86M
Net Income - Minority -27.43M-44.47M-67.93M-17.89M
Income from Non-Controlling Interests -5.46M-16.20M-32.96M-57.79M-61.70M56.46M-100.12M-127.34M93.52M74.86M
Income from Continuing Operations -3.67M-10.71M-34.95M-27.61M-37.16M-21.33M-53.88M-71.29M-99.03M-130.80M-101.66M-102.98M-164.85M-213.91M-154.15M-120.86M
Consolidated Net Income -3.67M-10.71M-34.95M-27.61M-37.16M-21.33M-53.88M-71.29M-2.32M-13.47M-101.66M-102.98M-164.85M-213.91M-154.15M-120.86M
Income towards Parent Company -3.67M-10.71M-34.95M-27.61M-37.16M-21.33M-81.31M-115.76M-70.25M-31.36M-101.66M-102.98M-164.85M-213.91M-154.15M-120.86M
Preferred Dividend Payments 8.03M8.03M9.89M
Net Income towards Common Stockholders -3.67M-9.98M-42.22M-27.61M-37.16M-21.33M-81.31M-115.76M-70.25M-31.36M-101.66M-102.98M-164.85M-94.61M-68.67M-55.89M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.47M0.47M1.63M2.37M2.95M3.14M3.26M3.38M3.78M4.72M6.25M6.64M7.24M8.94M27.60M
Shares Outstanding (Diluted Average) 81.70M5.92M8.11M20.78M
EBITDA -2.61M-9.24M-35.04M-27.18M-35.78M-20.63M-50.51M-65.31M-89.10M-120.00M-110.82M-94.27M-188.54M-203.56M-142.34M-110.38M